Company Overview

Cannabix Technologies Inc. is a Canada-based technology company focused on the development of cannabis detection and alcohol screening technologies for law enforcement, workplace safety, and public safety markets. The company operates at the intersection of the biotechnology, public safety, and diagnostic technology industries, with its core objective centered on creating a reliable marijuana breathalyzer capable of detecting recent THC consumption.

The company’s primary business activity is research, development, and commercialization of proprietary breath testing devices, with no material recurring operating revenue reported in recent public disclosures. Cannabix’s strategic positioning is based on first-mover advantage in a highly regulated and underserved market, particularly as cannabis legalization expands globally and demand increases for impairment detection tools. Founded in 2014, the company has evolved from an early-stage concept developer into a patent-focused R&D organization with multiple prototype devices under development and testing.

Business Operations

Cannabix operates primarily as a development-stage company, with operations focused on research and intellectual property development rather than large-scale commercial sales. Its core operating activities center on the Cannabix Marijuana Breathalyzer program, which includes multiple prototype platforms designed to detect THC and related metabolites from human breath samples.

The company’s operations are primarily based in Canada, with research, engineering, and administrative functions centralized at its corporate headquarters. Cannabix maintains laboratory testing, device engineering, and intellectual property management capabilities internally, while also utilizing third-party research institutions and technical consultants for validation and testing. As of the most recent publicly available filings, the company does not report material revenue-generating subsidiaries, and its business model is dependent on future commercialization, licensing, or strategic partnerships.

Strategic Position & Investments

Cannabix’s strategic direction is centered on advancing its proprietary breathalyzer technologies toward regulatory acceptance and commercial deployment. Key initiatives include continued refinement of device accuracy, miniaturization, and reliability, as well as patent filings intended to protect core detection methodologies. The company has publicly disclosed multiple issued and pending patents related to breath-based THC detection.

Investment activity has primarily consisted of internal R&D spending rather than external acquisitions. Cannabix has explored collaborations with academic and scientific institutions for independent testing and validation of its technology, though details of long-term commercial partnerships remain limited. The company’s strategic exposure is concentrated in emerging public safety technologies related to cannabis impairment detection, a sector still in early regulatory and commercial development stages.

Geographic Footprint

Cannabix Technologies Inc. is headquartered in Burnaby, British Columbia, Canada, which serves as the center of its executive management and research operations. The company’s operational footprint is relatively concentrated, reflecting its status as a development-stage technology firm.

While direct commercial operations are primarily domestic, Cannabix positions its technology for use in North America, Europe, and other regions where cannabis legalization and impaired driving enforcement are evolving. The company’s international influence is currently indirect, driven by patent coverage and regulatory monitoring rather than established overseas subsidiaries or manufacturing operations.

Leadership & Governance

Cannabix is led by its founder, who maintains a central role in shaping the company’s technical and strategic direction. The leadership team emphasizes long-term intellectual property development, regulatory alignment, and scientific validation as core pillars of corporate governance and decision-making.

Key executives include:

• Rav Mlait – Chief Executive Officer
• Kal Malhi – Director
• Richard L. Walchuk – Director
• Mark Gibson – Director

The company is governed by a board of directors with experience in public company management, capital markets, and early-stage technology development. Leadership philosophy is oriented toward disciplined R&D investment, patent protection, and cautious advancement toward commercialization in a highly regulated environment.